AUSTIN, Texas, Jan. 2, 2019 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that the company has completed its previously announced acquisition of MilliporeSigma’s flow cytometry portfolio for $75 million in combined stock, asset and inventory purchases. The acquisition is expected to contribute $40 million to $50 million in revenue to Luminex in 2019. “We are pleased... Read more
27 NOV 2018 | DARMSTADT, GERMANY MilliporeSigma’s proxy-CRISPR wins Special Recognition Market Disruptor — Products award Burlington, Massachusetts, November 27, 2018 – MilliporeSigma today announced that it has won two R&D 100 Awards. The 56th annual R&D 100 Awards program, honoring the 100 most innovative and significant technologies introduced in the past year, recognized MilliporeSigma for its BioReliance® Viral and Gene Therapy Assay... Read more
News Release November 19, 2018 Your Contact: Karen Tiano +1 978 495 0093 Twelve student finalists awarded in three fields: bioseparations, food & beverage safety and tumor biology Grand prize winners Yu Cai, University of Colorado; Yanqi Qu, University of Massachusetts Amherst and Jun Ho Lee, Ulsan National Institute of Science and Technology, each awarded... Read more
News Release November 5, 2018 Your Contact: Karen Tiano +1 978 495 0093 New BioContinuum™ Platform provides benefits now, with a mind to continuous process of the future Expanded Pellicon® Single-Pass Tangential Flow Filtration to intensify operations in the purification of therapeutic proteins Burlington, Massachusetts, November 5, 2018 — MilliporeSigma today launched its new BioContinuum™ Platform to advance... Read more
All associated reagents under these brands included in the deal Strategic agreement allows Luminex to increase footprint in multi-billion-dollar flow cytometry market Deal expected to close at end of 2018 Burlington, Massachusetts, October 18, 2018 — MilliporeSigma today announced the signing of a definitive agreement to sell its Flow Cytometry unit to Luminex Corporation for $75... Read more
News Release October 4, 2018 Your Contact: Karen Tiano +1 978 495 0093 New collaboration center to provide support from pre-clinical through full-scale production in a non-GMP environment Hands-on customer access to MilliporeSigma’s product portfolio, technical expertise Burlington, Massachusetts, October 4, 2018 — MilliporeSigma today officially opened a state-of-the-art M Lab™ Collaboration Center in Brazil, serving the Latin... Read more
News Release October 2, 2018 Your Contact: Karen Tiano +1 978 495 0093 Four graduate student chemists awarded for innovation in synthetic organic chemistry Tim Gatzenmeier, Max-Planck-Institut für Kohlenforschung, selected for grand prize Burlington, Massachusetts, October 2, 2018 — MilliporeSigma recognized four graduate students for their research and innovations in synthetic organic chemistry as part of... Read more
Burlington, Massachusetts, September 18, 2018 – MilliporeSigma today announced the opening of a new 3,800-square-meter laboratory in Singapore. 18 SEP 2018 | BURLINGTON, MASSACHUSETTS, UNITED STATES OF AMERICA First GMP BioReliance® biosafety testing lab in Asia Pacific offering critical testing services to bring life-changing therapies to market Extensive range of upstream and downstream bioprocessing solutions through M Lab™... Read more
Merck KGaA, Darmstadt, Germany, today announced that the Australian Patent Office has allowed the company’s patent application for the use of paired CRISPR nickases. 15 AUG 2018 | DARMSTADT, GERMANY Patent covers paired Cas9 nickase technology to reduce off-target effects, advance gene therapy and research Expands company’s foundational CRISPR cutting and integration IP necessary to correct genetic... Read more
News Release July 26, 2018 Your Contact: Karen Tiano +1 978 495 0093 Platform for creating sustained release formulations for virtually any class of biological API Eliminates pharmaceutical development hurdles MilliporeSigma’s global footprint makes InnoCore’s proprietary SynBiosys® drug delivery technology platform more widely available Burlington, Massachusetts, July 26, 2018 — MilliporeSigma and InnoCore Pharmaceuticals; Groningen, Netherlands, have... Read more